Surlorian
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
5147 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 117 | 75 | 33 | 3 | 49 | 244 |
| Healthy volunteers/patients | — | — | — | 112 | 9 | 4 | 9 | 24 | 152 |
| Prostatic neoplasms | D011471 | — | C61 | 25 | 67 | 23 | 1 | 36 | 137 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 15 | 19 | 25 | 17 | 33 | 108 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 11 | 15 | 18 | 11 | 46 | 98 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 9 | 24 | 18 | 2 | 44 | 95 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 19 | 37 | 12 | 9 | 23 | 92 |
| Colorectal neoplasms | D015179 | — | — | 25 | 32 | 15 | 1 | 27 | 89 |
| Covid-19 | D000086382 | — | U07.1 | 19 | 33 | 29 | 6 | 12 | 85 |
| Infections | D007239 | EFO_0000544 | — | 18 | 23 | 14 | 7 | 24 | 82 |
Show 343 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 48 | 97 | 58 | — | 60 | 235 |
| Non-small-cell lung carcinoma | D002289 | — | — | 47 | 74 | 36 | — | 6 | 143 |
| Lung neoplasms | D008175 | — | C34.90 | 24 | 41 | 19 | — | 20 | 93 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 21 | 31 | 13 | — | 7 | 65 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 26 | 34 | 11 | — | 4 | 62 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 17 | 31 | 9 | — | 10 | 59 |
| Multiple myeloma | D009101 | — | C90.0 | 26 | 20 | 8 | — | 8 | 55 |
| Lymphoma | D008223 | — | C85.9 | 30 | 22 | 6 | — | 4 | 54 |
| Head and neck neoplasms | D006258 | — | — | 18 | 21 | 5 | — | 10 | 46 |
| Myelodysplastic syndromes | D009190 | — | D46 | 14 | 22 | 8 | — | 1 | 41 |
Show 373 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Motor activity | D009043 | EFO_0003940 | — | — | 4 | — | — | 17 | 21 |
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 4 | 10 | — | — | 1 | 13 |
| Smoking cessation | D016540 | EFO_0004319 | — | — | 3 | — | — | 9 | 12 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 2 | 7 | — | — | 1 | 10 |
| Gliosarcoma | D018316 | — | — | 8 | 8 | — | — | — | 10 |
| Nasopharyngeal neoplasms | D009303 | — | — | 3 | 5 | — | — | 3 | 10 |
| Ischemic stroke | D000083242 | — | — | 1 | 1 | — | — | 8 | 10 |
| Ulcer | D014456 | MPATH_579 | — | 1 | 3 | — | — | 6 | 10 |
| Biliary tract neoplasms | D001661 | — | C24.9 | 2 | 7 | — | — | 1 | 9 |
| Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | 4 | 5 | — | — | 1 | 8 |
Show 363 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Drug interactions | D004347 | — | — | 7 | — | — | — | 1 | 8 |
| Pharmacokinetics | D010599 | — | — | 7 | — | — | — | — | 7 |
| Diagnostic imaging | D003952 | — | — | 7 | — | — | — | — | 7 |
| Food diet and nutrition | D000066888 | — | — | 1 | — | — | — | 5 | 6 |
| Cocaine-related disorders | D019970 | — | F14 | 5 | — | — | — | — | 5 |
| Osteosarcoma | D012516 | — | — | 4 | — | — | — | — | 4 |
| Phenylketonurias | D010661 | — | E70.0 | 1 | — | — | — | 3 | 4 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 2 | — | — | — | 2 | 4 |
| Hematopoietic stem cell transplantation | D018380 | — | — | 1 | — | — | — | 2 | 3 |
| Primary dysautonomias | D054969 | — | — | 1 | — | — | — | 2 | 3 |
Show 92 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sleep | D012890 | GO_0030431 | — | — | — | — | — | 9 | 9 |
| Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 8 | 8 |
| Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 8 | 8 |
| Psychological well-being | D000092862 | — | — | — | — | — | — | 8 | 8 |
| Communication | D003142 | — | — | — | — | — | — | 6 | 6 |
| Adenoma | D000236 | — | — | — | — | — | — | 6 | 6 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 6 | 6 |
| Patient acceptance of health care | D010342 | — | — | — | — | — | — | 6 | 6 |
| Mental health | D008603 | EFO_0003935 | — | — | — | — | — | 6 | 6 |
| Surgical amputation | D000671 | — | — | — | — | — | — | 6 | 6 |
Show 606 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use